LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
1.160
+0.020 (1.75%)
At close: May 12, 2025, 4:00 PM
1.220
+0.060 (5.17%)
After-hours: May 12, 2025, 7:59 PM EDT
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $22.13 million as of May 12, 2025. Its market cap has decreased by -83.80% in one year.
Market Cap
22.13M
Enterprise Value
46.80M
1-Year Change
-83.80%
Ranking
Category
Stock Price
1.16
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $22.13M, a decrease of -90.28%. That is a compound annual growth rate of -46.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 21.75M | -67.05% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |